Dysfunction of the hypothalamic-pituitary system in mitochondrial encephalomyopathies

被引:0
|
作者
Ohkoshi, N [1 ]
Ishii, A [1 ]
Shiraiwa, N [1 ]
Shoji, S [1 ]
Yoshizawa, K [1 ]
机构
[1] Univ Tsukuba, Inst Clin Med, Dept Neurol, Tsukuba, Ibaraki 305, Japan
关键词
chronic progressive external ophthalmoplegia; endocrine abnormality; mitochondrial encephalomyopathy; MELAS; MERRF (as defined below); pituitary hormone;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We investigated endocrine function in patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS), myoclonus epilepsy associated with ragged-red fibers (MERRF), and chronic progressive external ophthalmoplegia (CPEO). Hypothalamic-pituitary function was impaired in all three patients with MELAS or MERRF, but none of four with CPEO. A MELAS patient with dwarfism and impaired adolescent development had decreased growth hormone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH). A MERRF patient had emaciation and low adrenocorticotropin. A patient with mitochondrial encephalomyopathy transitional between MELAS and MERRF showed delayed, blunted LH and FSH response to LH-releasing hormone stimulation. We concluded that patients with mitochondrial encephalomyopathies, especially MELAS or MERRF, are like ly to have hypothalamic-pituitary dysfunction.
引用
收藏
页码:13 / 29
页数:17
相关论文
共 50 条
  • [41] Evaluation of a Mitochondrial Disease Criteria Scoring System on Mitochondrial Encephalomyopathy in Chinese Patients
    Niu, Feng-Nan
    Chang, Lei-Lei
    Meng, Fan-Qing
    Zhang, Ping
    Niu, Qi
    Zhang, Shen-Ning
    Wang, Zhong-Yuan
    Xu, Yun
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2013, 123 (02) : 93 - 98
  • [42] Mitochondrial dysfunction and cerebral metabolic abnormalities in patients with mitochondrial encephalomyopathy subtypes: Evidence from proton MR spectroscopy and muscle biopsy
    Niu, Feng-Nan
    Meng, Hai-Lan
    Chang, Lei-Lei
    Wu, Hong-Yan
    Li, Wei-Ping
    Liu, Ren-Yuan
    Wang, Hui-Ting
    Zhang, Bing
    Xu, Yun
    CNS NEUROSCIENCE & THERAPEUTICS, 2017, 23 (08) : 686 - 697
  • [43] CENTRAL-NERVOUS-SYSTEM CHANGES IN MITOCHONDRIAL ENCEPHALOMYOPATHY - LIGHT AND ELECTRON-MICROSCOPIC STUDY
    MIZUKAMI, K
    SASAKI, M
    SUZUKI, T
    SHIRAISHI, H
    KOIZUMI, J
    OHKOSHI, N
    OGATA, T
    MORI, N
    BAN, S
    KOSAKA, K
    ACTA NEUROPATHOLOGICA, 1992, 83 (04) : 449 - 452
  • [44] Mitochondrial dysfunction and organic aciduria in five patients carrying mutations in the Ras-MAPK pathway
    Tjitske Kleefstra
    Saskia B Wortmann
    Richard J T Rodenburg
    Ernie M H F Bongers
    Kinga Hadzsiev
    Cees Noordam
    Lambert P van den Heuvel
    Willy M Nillesen
    Katalin Hollody
    Gabrielle Gillessen-Kaesbach
    Martin Lammens
    Jan A M Smeitink
    Ineke van der Burgt
    Eva Morava
    European Journal of Human Genetics, 2011, 19 : 138 - 144
  • [45] Mitochondrial dysfunction and organic aciduria in five patients carrying mutations in the Ras-MAPK pathway
    Kleefstra, Tjitske
    Wortmann, Saskia B.
    Rodenburg, Richard J. T.
    Bongers, Ernie M. H. F.
    Hadzsiev, Kinga
    Noordam, Cees
    van den Heuvel, Lambert P.
    Nillesen, Willy M.
    Hollody, Katalin
    Gillessen-Kaesbach, Gabrielle
    Lammens, Martin
    Smeitink, Jan A. M.
    van der Burgt, Ineke
    Morava, Eva
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2011, 19 (02) : 138 - 144
  • [46] The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence
    Allison Hanaford
    Simon C. Johnson
    Orphanet Journal of Rare Diseases, 17
  • [47] The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence
    Hanaford, Allison
    Johnson, Simon C.
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [48] Activation of the mitochondrial protein quality control system and actin cytoskeletal alterations in cells harbouring the MELAS mitochondrial DNA mutation
    Felk, Sandra
    Ohrt, Susanne
    Kussmaul, Lothar
    Storch, Alexander
    Gillardon, Frank
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 295 (1-2) : 46 - 52
  • [49] KL1333, a Novel NAD+ Modulator, Improves Energy Metabolism and Mitochondrial Dysfunction in MELAS Fibroblasts
    Seo, Kang-Sik
    Kim, Jin-Hwan
    Min, Ki-Nam
    Moon, Jeong-A
    Roh, Tae-Chul
    Lee, Mi-Jung
    Lee, Kang-Woo
    Min, Ji-Eun
    Lee, Young-Mock
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [50] Hypothalamic growth hormone deficiency and supplementary GH therapy in two patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes
    Matsuzaki, M
    Izumi, T
    Shishikura, K
    Suzuki, H
    Hirayama, Y
    NEUROPEDIATRICS, 2002, 33 (05) : 271 - 273